Last updated 25 days ago

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

1000 patients around the world

Available in Mexico

Eli Lilly and Company

1000Patients around the world

This study is for people with

Migraine

Requirements for the patient

To 17 Years

All Gender

Medical requirements

: Participants must have completed study H8H-MC-LAHX (NCT03988088) or study H8H-MC-LAHV (NCT number to be determined)
Participants must weigh at least 15 kilograms (kg)

: Participants must not be pregnant or nursing
Participants must not have any acute, serious, or unstable medical condition
Participants must not be actively suicidal or at significant risk for suicide, in the opinion of the investigator

StudyPIONEER-PEDS2

SponsorEli Lilly and Company

Study typeInterventional

Conditions

Requirements

To 17 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT04396574